Investor insights
Sectors invested in
Biotechnology3
Health Care2
Pharmaceutical2
PCR1
Medical1
Big Data1
Therapeutics1
IVD1
分子檢測1
Funding rounds participated in
$30M sweet spot round size
Most of their 4 investments are in rounds between $20M and $41M
Investor type
Hedge Fund
Basic info
Industry
financial services
Sectors
Biotechnology
Pharmaceutical
Asset Management
Hedge Fund
Emerging Markets Healthcare
Healthcare Investing
Life Science
Minority Owned
Emerging Markets
Health Care
Impact Investor
Financial Services
Diversity and Inclusion
Medical Device
Biotech Investing
Date founded
2018
Investments made
I
IMPACT Therapeutics, Inc. raised undisclosed on March 14, 2022
Investors: Lilly Asia Ventures, 深圳市鼎心资本管理有限公司, YUEXIU GROUP and Exome Asset Management
U
Undisclosed raised undisclosed on January 28, 2021
Investors: Summer Capital, FountainVest Partners and Exome Asset Management
C
Centrexion Therapeutics Corp. raised $41M on October 29, 2020
Investors: Exome Asset Management
诺
诺辉健康 New Horizon Health Limited raised $20M on April 21, 2020
Investors: Qiming Venture Partners, SoftBank China Capital and Exome Asset Management